SCHEMBL233674

SCHEMBL233674

CC1CC(O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6758331 1.00
SCHEMBL4417294 1.00
SCHEMBL12016560 0.96
SCHEMBL21814585 0.96 LMNA (0.36)
SCHEMBL21311000 0.96
SCHEMBL12936100 0.96
SCHEMBL4644495 0.96
SCHEMBL961521 0.96
SCHEMBL3886823 0.93 LMNA (0.35)
SCHEMBL3886736 0.93 LMNA (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 335 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118201916-A Piperazinylsulfonylaryl compounds for the treatment of bacterial infections 豪夫迈·罗氏有限公司 2024-06-14 CN claimed
EP-4370206-A1 ESTERS OF 7-COOH CBD DERIVATIVES AND THEIR USE AS PREVENTION, PROPHYLAXIS OF PROGRESSION, AND/OR TREATMENT OF NEUROGENERATIVE DISEASES Receptorpharma Inc S-Corp (US) 2024-05-22 EP claimed
WO-2023285072-A1 ESTERS OF 7-COOH CBD DERIVATIVES AND THEIR USE AS PREVENTION, PROPHYLAXIS OF PROGRESSION, AND/OR TREATMENT OF NEUROGENERATIVE DISEASES. RECEPTORPHARMA INC S-CORP (US) 2023-01-19 WO claimed
US-20130149281-A1 ORGANIC COMPOUNDS AND THEIR USES NOVARTIS AG (CH) 2013-06-13 US claimed
US-8445527-B2 Organic compounds and their uses NOVARTIS AG (CH) 2013-05-21 US claimed
EP-2518079-A2 HCV/HIV inhibitors and their uses Novartis AG (CH) 2012-10-31 EP claimed
US-20120231998-A1 ORGANIC COMPOUNDS AND THEIR USES NOVARTIS AG (CH) 2012-09-13 US claimed
US-8211932-B2 Organic compounds and their uses NOVARTIS AG (CH) 2012-07-03 US claimed
US-20100331243-A1 ORGANIC COMPOUNDS AND THEIR USES NOVARTIS AG (CH) 2010-12-30 US claimed
US-7825152-B2 serine protease inhibitors, for the treatment of hepatitis c virus infections NOVARTIS AG (CH) 2010-11-02 US claimed
US-20070286842-A1 Organic Compounds and Their Uses NOVARTIS AG (CH) 2007-12-13 US claimed
US-20250387402-A1 POLYSUBSTITUTED BENZENE COMPOUND AND PREPARATION METHOD AND USE THEREOF EVOPOINT BIOSCIENCES CO LTD (CN) 2025-12-25 US disclosed
US-12390472-B2 Polysubstituted benzene compound and preparation method and use thereof Evopoint Biosciences Co., Ltd. (CN) 2025-08-19 US disclosed
US-12391802-B2 Method of forming semicrystalline polyetherimide, and polyetherimide-containing composition SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2025-08-19 US disclosed
CN-115518593-B Alkyl nitrate preparation process and device 西安万德能源化学股份有限公司 2025-01-24 CN disclosed
US-4562296-A CATALYTIC PYRROLYSIS OF AN ALCOHOL AND/OR ALDEHYDE USING MIXED OXIDES OF IRON AND GROUP 4 METAL ETHYL CORPORATION (US) 1985-12-31 US disclosed
US-4520213-A Method for solvent recovery in solvent separation of ethanol from water INSTITUTE OF GAS TECHNOLOGY (US) 1985-05-28 US disclosed
US-4508928-A CONTACTING WITH PROPENE SOLVENT INSTITUTE OF GAS TECHNOLOGY (US) 1985-04-02 US disclosed
US-4225608-A ANTIDEPRESSANTS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1980-09-30 US disclosed
EP-0004288-A2 Phenoxyalkyl amines, pharmaceutical compositions containing them, and process for their preparation MERCK PATENT GmbH (DE) 1979-10-03 EP disclosed